Monitor for potential follow-on selling or downward revisions in guidance; CEO selling at this level may signal reduced conviction ahead of earnings or macro headwinds in dental/medical supply sector.
How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Mar 2 $81.37entry
- T+1 · 9mo ago −1.43%α −0.51% · $80.21
- T+5 · 8mo ago −4.02%α −2.81% · $78.10
- T+20 · 8mo ago −10.65%α −2.72% · $72.70
- T+60 · 6mo ago −9.18%α −18.51% · $73.90
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
HSIC insiders sold a total of $2.17M in open-market transactions over the past week, led by CEO Stanley Bergman selling $1.94M worth of shares. A separate grant of 30,723 non-cash shares to Frederick Lowery (also CEO) does not represent economic activity. The cluster is dominated by significant selling from top leadership.
Key Financial Metrics
Key Facts
- CEO Stanley Bergman sold 23,858 shares at $81.31, totaling $1.94 million in open-market disposition.
- Philip Laskawy sold 2,844 shares at $80.36, amounting to $228,544 in open-market sale.
- Frederick M. Lowery was granted 30,723 shares at $0, a non-cash, equity award with no immediate economic impact.
- Total open-market selling by insiders: $2.17 million over 7 days.
- Total insider selling represents ~0.024% of HSIC's $9.2B market cap, modest in relative terms but notable due to concentration in C-suite.
Financial Impact
$2.17 million in open-market share sales by executives
Risk Factors
- Perception of insider pessimism, especially given the scale of Bergman's sale.
- Potential for negative market reaction if no clear rationale (e.g., tax planning, diversification) is disclosed.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (3 trades, 7d window) | cluster-HSIC-1772834929568 |
Track record
24 reports on HSIC
4 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +10.65% at T+20 after the Mar 2, 2026 report. 4 of 5 went positive at some point.
Filters
- Nov 16, 2026today 8-K Neutral 2/10 Entry price pending
- Nov 12, 20264d ago SC 13G/A Bearish 4/10 Entry $86.14 Now $84.96 +1.37% settles Nov 19
- Nov 6, 202610d ago 3 Neutral 1/10 Entry $88.41 to $84.96 Now $84.96 −3.90% ▼ −3.90% −2.21% vs SPY
- Nov 3, 202613d ago 8-K Bullish 6/10 Entry $82.50 to $88.74 Now $84.96 +2.98% ▲ +7.56% +8.15% vs SPY
- Oct 8, 20265w ago 8-K Neutral 3/10 Entry $84.63 to $86.99 Now $84.96 +0.39% ▲ +2.79% +3.07% vs SPY
- Sep 22, 20267w ago 8-K Neutral 3/10 Entry $87.43 to $84.97 Now $84.96 −2.83% ▼ −2.81% −1.63% vs SPY
- Aug 4, 202614w ago 8-K Bullish 6/10 Entry $89.11 to $89.18 Now $84.96 −4.66% ▲ +0.08% +0.18% vs SPY
- Aug 4, 202614w ago Institutional Cluster Mixed 4/10 Entry $89.11 to $89.18 Now $84.96 −4.66% ▲ +0.08% +0.18% vs SPY
- Jul 30, 202615w ago 8-K Neutral 3/10 Entry $85.17 to $88.23 Now $84.96 −0.25% ▲ +3.59% −0.03% vs SPY
- Jun 11, 202622w ago Institutional Cluster Mixed 5/10 Entry $81.25 to $79.92 Now $84.96 +4.57% ▼ −1.64% −2.31% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers